Open Access

Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer

Retraction in: /10.3892/ijo.2022.5382

  • Authors:
    • Huaying Dong
    • Wei Wang
    • Ru Chen
    • Yu Zhang
    • Kejian Zou
    • Mulin Ye
    • Xionghui He
    • Fan Zhang
    • Jing Han
  • View Affiliations

  • Published online on: July 3, 2018     https://doi.org/10.3892/ijo.2018.4467
  • Pages: 1013-1026
  • Copyright: © Dong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Currently, resistance to trastuzumab, a human epidermal growth factor receptor 2 (HER2) inhibitor, has become an important obstacle to improving the clinical outcome of patients with advanced HER2+ breast cancer. While cell behavior may be modulated by long non‑coding RNAs (lncRNAs), the contributions of lncRNAs within extracellular vesicles (exosomes) are largely unknown. To this end, the involvement and regulatory functions of potential lncRNAs contained within exosomes during the formation of chemoresistance in human breast cancer were investigated. Trastuzumab-resistant cell lines were established by continuously grafting HER2+ SKBR-3 and BT474 cells into trastuzumab-containing culture medium. An lncRNA microarray assay followed by reverse transcription‑quantitative polymerase chain reaction analysis identified that lncRNA-small nucleolar RNA host gene 14 (SNHG14) was upregulated in trastuzumab-resistant cells when compared with parental breast cancer cells. Functional experimentation demonstrated that knockdown of lncRNA‑SNHG14 potently promoted trastuzumab-induced cytotoxicity. Furthermore, extracellular lncRNA‑SNHG14 was able to be incorporated into exosomes and transmitted to sensitive cells, thus disseminating trastuzumab resistance. Treatment of sensitive cells with exosomes highly expressing lncRNA‑SNHG14 induced trastuzumab resistance, while knockdown of lncRNA‑SNHG14 abrogated this effect. The Signal Transduction Reporter Array indicated that lncRNA‑SNHG14 may promote the effect of trastuzumab by targeting the apoptosis regulator Bcl‑2 (Bcl‑2)/apoptosis regulator BAX (Bax) signaling pathway. Furthermore, the expression level of serum exosomal lncRNA‑SNHG14 was upregulated in patients who exhibited resistance to trastuzumab, compared with patients exhibiting a response. Therefore, lncRNA‑SNHG14 may be a promising therapeutic target for patients with HER2+ breast cancer.
View Figures
View References

Related Articles

Journal Cover

September-2018
Volume 53 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dong H, Wang W, Chen R, Zhang Y, Zou K, Ye M, He X, Zhang F and Han J: Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer Retraction in /10.3892/ijo.2022.5382. Int J Oncol 53: 1013-1026, 2018.
APA
Dong, H., Wang, W., Chen, R., Zhang, Y., Zou, K., Ye, M. ... Han, J. (2018). Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer Retraction in /10.3892/ijo.2022.5382. International Journal of Oncology, 53, 1013-1026. https://doi.org/10.3892/ijo.2018.4467
MLA
Dong, H., Wang, W., Chen, R., Zhang, Y., Zou, K., Ye, M., He, X., Zhang, F., Han, J."Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer Retraction in /10.3892/ijo.2022.5382". International Journal of Oncology 53.3 (2018): 1013-1026.
Chicago
Dong, H., Wang, W., Chen, R., Zhang, Y., Zou, K., Ye, M., He, X., Zhang, F., Han, J."Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer Retraction in /10.3892/ijo.2022.5382". International Journal of Oncology 53, no. 3 (2018): 1013-1026. https://doi.org/10.3892/ijo.2018.4467